Abnormal processing of the amyloid precursor protein (APP) and -amyloid (A) plaque accumulation are defining features of Alzheimer disease (AD), a genetically complex neurodegenerative disease that is characterized by progressive synapse loss and neuronal cell death. A induces synaptic dysfunction in part by altering the endocytosis and trafficking of AMPA and NMDA receptors. Reelin is a neuromodulator that increases glutamatergic neurotransmission by signaling through the postsynaptic ApoE receptors Apoer2 and Vldlr and thereby potently enhances synaptic plasticity. Here we show that Reelin can prevent the suppression of long-term potentiation and NMDA receptors, which is induced by levels of A comparable to those present in an AD-afflicted brain. This reversal is dependent upon the activation of Src family tyrosine kinases. At high concentrations of A peptides, Reelin can no longer overcome the A induced functional suppression and this coincides with a complete blockade of the Reelin-dependent phosphorylation of NR2 subunits. We propose a model in which A, Reelin, and ApoE receptors modulate neurotransmission and thus synaptic stability as opposing regulators of synaptic gain control.Alzheimer disease ͉ apolipoprotein E ͉ long-term potentiation ͉ NMDA receptor ͉ A oligomer A lzheimer disease (AD) is a complex genetic neurodegenerative disease that afflicts an increasing fraction of our aging population (1). A characteristic feature of AD is the accumulation of oligomeric and higher-order aggregates of the A 1-42 form of the amyloid- (A) peptide, which is physiologically released by sequential proteolytic cleavage from the amyloid- precursor protein (APP) (2, 3). Abnormal, amyloidogenic A processing and plaque formation progressively lead to synaptic dysfunction, synapse loss, and ultimately neuronal death.Recent insight into the pathophysiological functions of A came from studies that demonstrated a potent negative impact of A oligomers on synaptic functions that underlie long-term synaptic plasticity (4-6). Incubation of hippocampal neurons and slices with A oligomers leads to intracellular trapping or functional impairment of AMPA and NMDA-type glutamate receptors (7-9), thereby decreasing long-term potentiation (LTP), an enhancement of synaptic strength that is correlated with memory (4, 5, 10-13). Consistent with these in vitro findings, Palop et al. (14,15) showed that overexpression of mutant APP forms in mice resulted in a global dysregulation of neuronal network activity in vivo.Reelin is a signaling protein that is produced by interneurons in the brain and that has an effect on synaptic functions that is opposite to that of A oligomers. Reelin addition to hippocampal slices results in enhanced LTP (16) as a result of the activation of Src family tyrosine kinases (SFKs) (17-19), which increase NMDA receptor activity by tyrosine phosphorylation of their NR2 subunits (20,21). These effects of Reelin are mediated by a pair of homologous cell surface receptors designated apolipoprotein E r...